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Hair Wnt awry
Because the genetic basis of the rare autosomal dominant 
form of hair miniaturization and loss, hereditary hypotrichosis 
simplex, is unknown, Shimomura and colleagues performed 
genetic linkage analysis and identified a mutation (Leu9Arg) in 
the adenomatosis polyposis downregulated 1 (APCDD1) gene 
in patients with this disease. The extracellular domain of the 
APCDD1 protein interacted with WNT3A and LRP5, two Wnt 
signaling proteins important for hair follicle induction. In addi-
tion, APCDD1 appears to be a membrane-tethered Wnt inhibi-
tor that functions in a cell-autonomous manner at the surface of 
the Wnt-receiving cell. Analysis of the functional ramifications 
of the Leu9Arg mutation revealed that this mutation probably 
acts in a dominant-negative manner to destabilize APCDD1 
and prevent its localization at the plasma membrane. These 
results support a requirement for controlled regulation of Wnt 
signaling during hair follicle morphogenesis and cycling, and, 
because of the overlap of the location of this gene and identi-
fied linkage intervals, this protein may be implicated in addi-
tional polygenic hair follicle disorders, such as androgenetic 
alopecia and alopecia areata. (Nature 464:1043–7, 2010)
Thwarting the vasculogenic potential
Although typically harmless and prone to spontaneous 
involution, infantile hemangiomas that are deemed dangerous 
or disfiguring are effectively treated with corticosteroids to 
stabilize or accelerate regression of the tumor via an incom-
pletely understood mechanism. Because previous work found 
hemangioma-derived stem cells at the origin of infantile 
hemangiomas, Greenberger and colleagues investigated 
the effects of corticosteroids on this cell type. The corti-
costeroid dex amethasone inhibited vasculogenesis induced by 
hemangioma-derived stem cells in mice. Dexamethasone also 
inhibited the secretion of vascular endothelial growth factor A 
(VEGF-A) by these cells in culture, and this suppression was 
sufficient to block the vasculogenic potential of the heman-
gioma-derived stem cells in the mouse model. These exciting 
findings may offer a foundation for future investigation of the 
mechanism of corticosteroid activity in hemangioma treatment 
and may illuminate possibilities for the development of addi-
tional therapies targeting VEGF and vasculogenesis. (N Engl J 
Med 362:1005–13, 2010)
Stop the bleed
Thalidomide, the teratogenic drug once commonly used to 
treat nausea in pregnant women, is currently used to inhibit 
bleeding in individuals with gastrointestinal diseases as well 
as in patients with hereditary hemorrhagic telangiectasia 
(HHT). HHT is an autosomal dominant disease in which vas-
cular malformations and subsequent bleeding occur because 
of decreased transforming growth factor-β activation and 
increased VEGF production. Treatment of HHT has remained 
challenging because of the dissemination of the vascular 
anomalies over entire mucosal surfaces. Lebrin and colleagues 
found that oral administration of thalidomide decreased both 
the frequency and the duration of epistaxis in HHT patients. 
Thalidomide exerted these effects by increasing the mural 
cell coverage of the vasculature, illuminating mural cells as a 
useful new target for vascular therapy. Thalidomide actually 
increased the proliferation and ability to form protrusions that 
embrace the blood vessels in mural cells. In addition, platelet-
derived growth factor-B was implicated as a key mediator in 
this process. (Nat Med 16:420–8, 2010)
Most primitive in the epidermis
The three epidermal compartments—the hair follicle (HF), the 
sebaceous gland (SG), and the interfollicular epidermis (IFE)—
are all capable of self-renewal. Although each of these skin cell 
populations is maintained by its own discrete stem cells during 
homeostatic conditions, disruption of these normal conditions 
can induce any of the three stem cell populations to produce 
all three structures. Following the identification of leucine-rich 
repeat-containing G protein (heterotrimeric guanine nucle-
otide-binding protein)-coupled receptor 5 (Lgr5) on HF stem 
cells that contribute to all hair lineages, but not to the SG or 
IFE, Snippert and colleagues found that the related Lgr6 was 
one of the earliest embryonic placode markers. Lgr6 marks a 
unique stem cell population that gives rise to all lineages of the 
skin, and, unlike its relative Lgr5, this protein appears to oper-
ate via a Wnt-independent mechanism. Furthermore, Lgr6+ 
cells functioned in long-term wound repair. Therefore, Lgr6 
appears to characterize the most primitive epidermal stem cell. 
(Science 327:1385–9, 2010)
Stiff skin stuff
Stiff skin syndrome (SSS) is a rare autosomal congenital form of 
scleroderma characterized by hard, thick skin, usually covering 
the entire body. Accumulating evidence indicates that fibrillin-1 
contributes to the pathogenesis of profibrotic phenotypes via a 
role in assembly of microfibrils and in regulation of the pro-
fibrotic cytokine transforming growth factor-β (TGF-β). Loeys 
and colleagues identified mutations in the integrin-binding TB4 
domain of fibrillin-1 in SSS in humans. These mutations were 
sufficient to initiate and maintain cutaneous profibrotic pheno-
types, and, in accord with previous data regarding fibrillin-1, 
these mutations altered microfibrillar assembly and microfibril–
integrin interactions via dysregulation of TGF-β signaling. 
Because similar phenotypic characteristics were found in 
biopsies from patients with the related, and more common, 
systemic sclerosis, these findings may have much broader 
clinical relevance. (Sci Transl Med 2:23ra20, 2010)
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